← Eichor
Study identifier: NCT04353778 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

Condition: HIV · Non-HIV · Vagus Nerve Dysfunction  ·  Sponsor: Icahn School of Medicine at Mount Sinai

PhasePhase 1/Phase 2
Planned participants207
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The study team's prior research has shown that dysfunction of a specific nerve, called the vagus nerve, is associated with small intestinal bacterial overgrowth (SIBO), and that SIBO is associated with signs of inflammation in the blood of people living with HIV (PLWH). This research will explore pathways linking vagal dysfunction to inflammation in HIV, focusing on the gastrointestinal tract, and study whether a medication called pyridostigmine and stimulation of the vagus nerve are beneficial therapies.

This description comes directly from the study's public registry record.

Talk to the study team

Niyati Neupane  ·  niyati.neupane@mssm.edu

Mary Catherine George, MM, PhD  ·  212-241-0784  ·  mary-catherine.george@mssm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Icahn School of Medicine at Mount SinaiNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04353778